MSC MALE SPERMACEIVE

LIVE

Serial Number

88125154

Owner

Global Medics USA

Attorney

Robert Chang

First Use Date

Feb 1, 2019

Filing Date

Sep 20, 2018

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

MSC MALE SPERMACEIVE Trademark

Serial Number: 88125154 • Registration: 5974921

MSC MALE SPERMACEIVE is a trademark filed by Global Medics USA on September 20, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Global Medics USA (8 trademarks)

17735 NE 65th Street Suite 130
Redmond, WA 98052

Entity Type: 16

Legal Representation

Attorney of Record

Robert Chang

34 trademarks filed View all →

Correspondence Address

Robert Chang Columbia IP Law

4957 Lakemont Blvd. SE

C4165

Bellevue, WA 98006

United States

Trademark Details

Filing Date

September 20, 2018

Registration Date

February 4, 2020

First Use Anywhere

February 1, 2019

First Use in Commerce

February 14, 2019

Published for Opposition

November 19, 2019

Goods & Services

Dietary supplements

Filing History

TEAS SECTION 8 & 15 RECEIVED

Aug 4, 2026 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Feb 4, 2025 REM1

REGISTERED-PRINCIPAL REGISTER

Feb 4, 2020 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 19, 2019 NPUB

PUBLISHED FOR OPPOSITION

Nov 19, 2019 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 30, 2019 NONP

ASSIGNED TO LIE

Oct 17, 2019 ALIE

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Oct 12, 2019 AAUA

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 11, 2019 CNSA

USE AMENDMENT ACCEPTED

Oct 11, 2019 IUAA

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 9, 2019 TEME

AMENDMENT TO USE PROCESSING COMPLETE

Apr 9, 2019 AUPC

USE AMENDMENT FILED

Apr 9, 2019 IUAF

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 8, 2019 TCCA

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 8, 2019 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 8, 2019 TROA

TEAS AMENDMENT OF USE RECEIVED

Apr 8, 2019 EAAU

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 22, 2019 GNRN

NON-FINAL ACTION E-MAILED

Jan 22, 2019 GNRT

NON-FINAL ACTION WRITTEN

Jan 22, 2019 CNRT

ASSIGNED TO EXAMINER

Jan 2, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 26, 2018 NWOS

NEW APPLICATION ENTERED

Sep 24, 2018 NWAP

Related Trademarks

More from this Owner

TRIBONMIX

PREGNOVA

FERTINOVA

More in Same Class

URGO MEDICAL, HEALING PEOPLE

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 2,200 MG PER 220 ML (10 MG/ML)

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 2,000 MG PER 200 ML (10 MG/ML)

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,900 MG PER 190 ML (10 MG/ML)

BLACKFORT

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML)